Research Topics
| Sonal SinghSummaryAffiliation: Johns Hopkins Bloomberg School of Public Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medicationsSonal Singh
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 1901, USA
Thorax 68:114-6. 2013..The authors urge caution in prescribing inhaled anticholinergics for patients with pre-existing arrhythmias or cardiac disorders...
Religion, health, and questions of meaningSonal Singh
Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland, USA
MedGenMed 7:74. 2005
HIV in Nepal: is the violent conflict fuelling the epidemic?Sonal Singh
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
PLoS Med 2:e216. 2005
Human rights violations among sexual and gender minorities in Kathmandu, Nepal: a qualitative investigationSonal Singh
Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
BMC Int Health Hum Rights 12:7. 2012..abstract:..
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisSonal Singh
Department of Medicine, One Medical Center Blvd, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
JAMA 300:1439-50. 2008..Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely used in patients with chronic obstructive pulmonary disease (COPD) but their effect on the risk of cardiovascular outcomes is unknown...
The safety of rosiglitazone in the treatment of type 2 diabetesSonal Singh
Wake Forest University School of Medicine, Department of Medicine, Winston Salem, NC 27103, USA
Expert Opin Drug Saf 7:579-85. 2008..The thiazolidinediones including rosiglitazone are approved for the treatment of Type 2 diabetes on the basis of their ability to lower blood sugar and surrogate markers of cardiovascular disease...
Conflict induced internal displacement in NepalSonal Singh
MPH Program, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA
Med Confl Surviv 23:103-10. 2007....
Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and updateSonal Singh
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
Curr Opin Pulm Med 16:118-22. 2010....
Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysisSonal Singh
Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St, Suite 8063, Baltimore, MD 21287, USA
Thorax 66:383-8. 2011..The authors aimed to systematically determine the risk of pneumonia or lower respiratory tract infections associated with thiazolidinediones...
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary diseaseSonal Singh
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
Int J Chron Obstruct Pulmon Dis 5:189-95. 2010..The benefit harm profile of inhaled corticosteroids, and their effect on patient oriented outcomes and comorbid pneumonia, osteoporosis and cardiovascular disease in patients with chronic obstructive pulmonary disease remain uncertain...
Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysisSonal Singh
Department of Medicine, Wake Forest University School of Medicine, One Medical Center Boulevard, Winston Salem, NC 27157, USA
Arch Intern Med 169:219-29. 2009..We aimed to ascertain the risk of pneumonia with long-term inhaled corticosteroid use among patients with chronic obstructive pulmonary disease (COPD)...
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysisSonal Singh
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
CMAJ 183:1359-66. 2011..We conducted a systematic review and meta-analysis of randomized controlled trials to ascertain the serious adverse cardiovascular effects of varenicline compared with placebo among tobacco users...
Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trialsSonal Singh
Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Baltimore, MD 21287, USA
BMJ 342:d3215. 2011..To systematically review the risk of mortality associated with long term use of tiotropium delivered using a mist inhaler for symptomatic improvement in chronic obstructive pulmonary disease...
The state of child health and human rights in NepalSonal Singh
Public Health Program, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
PLoS Med 3:e203. 2006
Network meta-analysis-highly attractive but more methodological research is neededTianjing Li
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21212, USA
BMC Med 9:79. 2011..Since this commentary reflects the discussion at that meeting, it is not intended to provide an overview of the field...
Impact of long-term political conflict on population health in NepalSonal Singh
Department of Medicine, Unity Health System, Rochester, New York, USA
CMAJ 171:1499-501. 2004
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysisSonal Singh
Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
JAMA 298:1189-95. 2007..Recent reports of serious adverse events with rosiglitazone use have raised questions about whether the evidence of harm justifies its use for treatment of type 2 diabetes...
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinationsWendy L Bennett
The Johns Hopkins University School of Medicine and The Johns Hopkins Bloomberg School of Public Health, 2024 East Monument Street, Baltimore, MD 21205, USA
Ann Intern Med 154:602-13. 2011..Given the increase in medications for type 2 diabetes mellitus, clinicians and patients need information about their effectiveness and safety to make informed choices...
Neglected diseases, civil conflicts, and the right to healthChris Beyrer
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
Lancet 370:619-27. 2007..We also discuss the role of researchers in advocating for and researching within oppressed populations...
A framework for organizing and selecting quantitative approaches for benefit-harm assessmentMilo A Puhan
Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E6153, Baltimore, MD 21205, USA
BMC Med Res Methodol 12:173. 2012..Our aim was to review existing quantitative approaches for benefit-harm assessment and to develop an organizing framework that clarifies differences and aids selection of quantitative approaches for a particular benefit-harm assessment...
Chapter 7: grading a body of evidence on diagnostic testsSonal Singh
Department of Medicine, Johns Hopkins University School of Medicine, 624 N Broadway, Baltimore, MD 21205, USA
J Gen Intern Med 27:S47-55. 2012..However if reviewers choose to combine domains into a single grade of evidence, they should explain their rationale for a particular summary grade and the relevant domains that were weighed in assigning the summary grade...
Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysisPooja Chaukiyal
Department of Medicine, Unity Health System, 1555 Long Pond Road, Rochester, NY 14626, USA
Thromb Haemost 99:38-43. 2008..The use of primary thromboprophylaxis in cancer patients with central venous catheters while not causing any harm provides no benefit...
Drug safety assessment in clinical trials: methodological challenges and opportunitiesSonal Singh
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Trials 13:138. 2012..Regulatory and academic partnerships should be fostered to provide an independent and transparent evaluation of drug safety...
Violations of human rights: health practitioners as witnessesJames Orbinski
Department of Family and Community Medicine, St Michael s Hospital, Toronto, Ontario, Canada
Lancet 370:698-704. 2007....
Prevalence of mental disorders and torture among Bhutanese refugees in Nepal: a systemic review and its policy implicationsEdward Mills
Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada
Med Confl Surviv 24:5-15. 2008..The international community must resolve this protracted crisis...
Special issue on South Asia: focus will be an eye openerSonal Singh
BMJ 328:288. 2004
Post-traumatic stress in former Ugandan child soldiersSonal Singh
Lancet 363:1648. 2004
Nepal's war and conflict-sensitive developmentSonal Singh
PLoS Med 2:e29. 2005
Letter from the HimalayasSonal Singh
CMAJ 171:309-10; author reply 310. 2004
Tears from the land of snow: health and human rights in TibetSonal Singh
Lancet 364:1009. 2004
The HIV/AIDS epidemic in CambodiaEdward Mills
Lancet Infect Dis 5:596-7. 2005
Designing research in vulnerable populations: lessons from HIV prevention trials that stopped earlyEdward J Mills
Department of Clinical Epidemiology and Biostatistics, McMaster University, HSC-2C12, 1200 Main Street West, Hamilton, ON, Canada L8N 3Z5
BMJ 331:1403-6. 2005
Sharing evidence on humanitarian reliefEdward J Mills
BMJ 331:1485-6. 2005
Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challengeEdward Mills
Centre for International Health and Human Rights Studies, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
PLoS Med 3:e94. 2006
Randomized trials stopped early for harm in HIV/AIDS: a systematic surveyEdward Mills
Centre for International Health and Human Rights Studies, North York, Ontario, Canada
HIV Clin Trials 7:24-33. 2006..We assessed the prevalence of randomized clinical trials (RCTs) stopped early for harm in HIV/AIDS and determined the quality of reporting of methods to inform the decision to stop the trial...
Clinical Research in Emerging Countries--Third Annual Marcus Evans ConferenceSonal Singh
Wake Forest University School of Medicine, Section on General Internal Medicine, One Medical Center Boulevard, Winston-Salem, NC 27157, USA
IDrugs 11:724-7. 2008
Free doctors and medical students detained in NepalSonal Singh
Lancet 367:1730. 2006
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysisEdward J Mills
Centre for International Health and Human Rights Studies, Toronto, Ontario, Canada
JAMA 296:679-90. 2006..Concerns about incomplete adherence among patients living in poverty have been an important consideration in expanding the access to antiretroviral therapy in sub-Saharan Africa...
Dangerous journey: documenting the experience of Tibetan refugeesSonam Dolma
Department of Political Science, York University, Toronto, Ontario
Am J Public Health 96:2061-4. 2006..International pressure is needed to prevent human rights violations and reduce potential long-term physical and mental health effects associated with this dangerous crossing...
The impact of conflict on HIV/AIDS in sub-Saharan AfricaEdward J Mills
Centre for International Health and Human Rights Studies, Toronto, Canada
Int J STD AIDS 17:713-7. 2006..We examine the complexity of monitoring HIV/AIDS in conflict settings. We argue that increased efforts are needed to protect vulnerable populations and design health-delivery systems that are sustainable in settings of conflict...
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitatorsEdward J Mills
Centre for International Health and Human Rights Studies, Toronto, Ontario, Canada
PLoS Med 3:e438. 2006..We systematically reviewed the literature to determine patient-reported barriers and facilitators to adhering to antiretroviral therapy...
